INGENIUM PHARMACEUTICALS AG
Ingenium Pharmaceuticals AG is discovers and develops molecules for the treatment of neuronal and autoimmune diseases.
INGENIUM PHARMACEUTICALS AG
Social Links:
Industry:
Biotechnology
Founded:
1997-01-01
Address:
Planegg, Bayern, Germany
Country:
Germany
Website Url:
http://www.probiodrug.de
Total Employee:
1+
Status:
Active
Contact:
+49 89 8565 2300
Total Funding:
43.98 M USD
Similar Organizations
Apogenix
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.
Avid Radiopharmaceuticals
Avid Radiopharmaceuticals develops molecular imaging agents for detecting and monitoring chronic human diseases.
Neurofix
Neurofix mission is to discover and develop molecules for the treatment of pathologies of the central nervous system.
Investors List
Thuja Capital
Thuja Capital investment in Venture Round - Ingenium Pharmaceuticals AG
German Federal Ministry of Education and Research (BMBF)
German Federal Ministry of Education and Research (BMBF) investment in Grant - Ingenium Pharmaceuticals AG
New Medical Technologies
New Medical Technologies investment in Series B - Ingenium Pharmaceuticals AG
Lehman Brothers
Lehman Brothers investment in Series B - Ingenium Pharmaceuticals AG
Index Ventures
Index Ventures investment in Series B - Ingenium Pharmaceuticals AG
IKB Deutsche Industriebank
IKB Deutsche Industriebank investment in Series B - Ingenium Pharmaceuticals AG
Sofinnova Partners
Sofinnova Partners investment in Series B - Ingenium Pharmaceuticals AG
Bayern Kapital
Bayern Kapital investment in Series B - Ingenium Pharmaceuticals AG
Schroder Ventures
Schroder Ventures investment in Series B - Ingenium Pharmaceuticals AG
Deutsche Bank
Deutsche Bank investment in Series B - Ingenium Pharmaceuticals AG
Official Site Inspections
http://www.probiodrug.de
- Host name: dd53506.kasserver.com
- IP address: 85.13.129.136
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Ingenium Pharmaceuticals AG"
Probiodrug AG becomes Vivoryon Therapeutics AG - Vivoryon
Jun 12, 2019 Healthy Aging – Pioneering Innovation. HALLE (SAALE), Germany, 12 June 2019 – Probiodrug AG (Euronext Amsterdam: currently PBD, to be changed to VVY, ISIN: …See details»
Probiodrug AG - Halle (Saale), Germany - bionity.com
Nov 30, 2012 Probiodrug is a biopharmaceutical company focused on the development of innovative small molecule drugs for the treatment of neuronal, inflammatory, and autoimmune …See details»
Probiodrug - VentureRadar
Enterome France Privately Held Enterome is a clinical stage biopharmaceutical company developing novel drugs based on its unique ability to de-code molecular interactions in the gut …See details»
Probiodrug AG - Halle (Saale), Deutschland - bionity.com
Probiodrug.de +493455559900. Teilen. Xing Linkedin Facebook X E-mail Loading... Merken. Merkliste aufrufen; Merken. Probiodrug AG. Weinbergweg 22 06120 Halle (Saale) ... Evotec …See details»
Probiodrug AG to hold its Ordinary General Meeting of …
May 9, 2018 Probiodrug Dr Ulrich Dauer, CEO Email: [email protected] Optimum Strategic Communications Mary Clark, Supriya Mathur, Hollie Vile Tel: +44 (0) 203 714 1787 …See details»
Probiodrug heißt jetzt Vivoryon Therapeutics | CHEManager
Jun 12, 2019 Probiodrug hat sich mit der Eintragung in das Handelsregister Stendal zum 11. Juni 2019 offiziell in Vivoryon Therapeutics umbenannt. Laut CEO Ulrich Dauer steht der neue …See details»
Probiodrug AG - Profile
Probiodrug’s lead product candidate, PQ912, is a highly specific and potent inhibitor of Glutaminyl Cyclase (QC), which has shown therapeutic effects in Alzheimer’s animal models. PQ912 is …See details»
Probiodrug (AG) | TREA
Explore innovation relationships and map ideas to the unified knowledge graphSee details»
Probiodrug ag information - Employees, Contact info
View information on-Probiodrug ag (vivoryon.com),Located in Weinbergweg 22, Halle (Saale), Saxony-Anhalt 06120, DE. Find over 8 employees information, adress, official website, private …See details»
Probiodrug und die Alzheimer’s Disease Cooperative Study (ADCS ...
Probiodrug Dr. Ulrich Dauer, CEO Email: [email protected] The Alzheimer’s Disease Cooperative Study Howard Feldman, MD Email: [email protected] MC Services AG …See details»
Probiodrug - News, Articles, Whitepapers - Drug Target Review
Mar 20, 2015 Probiodrug and Crossbeta team up for Alzheimer’s disease biomarkers. 30 June 2016 | By Victoria White, Digital Content Producer. The partnership will allow Probiodrug to …See details»
German Alzheimer's drug developer Probiodrug plans Amsterdam …
Sep 25, 2014 Germany's Probiodrug AG, a developer of treatments for Alzheimer's disease plans to list its shares in Amsterdam via an initial public offer (IPO), it said on Thursday, …See details»
Probiodrug : becomes Vivoryon Therapeutics AG - MarketScreener
HALLE (SAALE), Germany, 12 June 2019 - Probiodrug AG (Euronext Amsterdam: currently PBD, to be changed to VVY, ISIN: DE0007921835), focusing on the discovery and development of …See details»
Wirkstoff getestet: Probiodrug aus Halle will Alzheimer besiegen
Aug 1, 2017 Probiodrug begann als reines Pharmaforschungsunternehmen - und mauserte sich zur Jahrtausendwende zu einem Leuchtturm unter den innovativen Firmen Ostdeutschlands. …See details»
www.probiodrug.de New therapeutic strategy for treating ... - Nature
Probiodrug’s novel approach targets a modified form of β-amyloid, which has a key role in the creation of toxic A β oligomers. The company’s lead product is a first-in-class oral small ...See details»
Probiodrug : Probiodrug AG to Publish its Third Quarter 2017 …
Nov 23, 2017 Probiodrug AG to Publish its Third Quarter 2017 Business Update on 30 November 2017. HALLE (SAALE), Germany, 23 November 2017 - Probiodrug AG (Euronext …See details»
Probiodrug AG: Probiodrug and Crossbeta Biosciences extend …
Probiodrug / Probiodrug AG: Probiodrug and Crossbeta Biosciences extend their strategic partnership in the field of Alzheimer's disease biomarkers . Processed and transmitted by …See details»
Probiodrug AG to hold its Ordinary General Meeting of …
HALLE (SAALE), Germany, 18 April 2019 – Probiodrug AG (Euronext Amsterdam: PBD; ISIN: DE0007921835), invites all shareholders to Probiodrugs ordinary general meeting of …See details»
An update and overview of the various health‐related benefits of ...
Other studies have examined inflammatory markers in patients with type 2 diabetes, including those with multiple strains. Mohamadshahi et al. and Tonucci et al. examined the effects of …See details»
Probiodrug wirbt in einer erfolgreichen Privatplatzierung von …
Probiodrug AG Weinbergweg 22 [email protected] www.probiodrug.com 06120 Halle (Saale) Germany ### Weitere Informationen erhalten Sie von: Probiodrug Dr. Ulrich Dauer, …See details»